col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


107 Ergebisse       Seite 1

 [1] 
American Chemical Society: ACS Infectious Diseases
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Dez―19 Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases Margaret A. Brimble, Louise A. Stubbing, Yann O. Hermant, Sung-Hyun Yang, Jonathan G. Hubert, Esperanza S. Pearl, et al. (+13)
2 [GO] 2025―Sep―26 Dual-Site Inhibition of SARS-CoV-2 RNA-Dependent RNA Polymerase by Small Molecules Able to Block Viral Replication Identified through a Computer-Aided Drug Discovery Approach Paolo Malune, Daniela Iaconis, Candida Manelfi, Stefano Giunta, Roberta Emmolo, Filippo Lunghini, et al. (+6)
3 [GO] 2025―Sep―12 A High-Throughput Broad Neutralizing Antibody Assay for Detecting SARS-CoV-2 Variant Immunity in Population Xiaohan Zhang, Yajie Wang, Mansheng Li, Haolong Li, Xiaomei Zhang, Xingming Xu, et al. (+12)
4 [GO] 2025―Jul―17 Targeting G-Quadruplex with Bis-thiourea Compounds Inhibits SARS-CoV-2 Replication Shogo Sasaki, Shogo Nakajima, Rena Nohara, Hiroyuki Endo, Norito Takeuchi, Taiji Oyama, et al. (+7)
5 [GO] 2025―Jul―17 Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity Yuanmei Wen, Jun Zhou, Fan Pan, Peisen Zheng, Fengxia Zhong, Sidi Yang, et al. (+5)
6 [GO] 2025―Jul―11 Functional Phenotyping of MMV Pandemic Response Box Identifies Stage and Mechanism-Specific Inhibitors against Blood Stage Plasmodium falciparum Akhila T.P., Darsana K.M., Rajesh Chandramohanadas
7 [GO] 2025―Jun―17 SARS-CoV-2 Evolved Variants Bind to Sialylated Gangliosides and Are Inhibited by a Tetravalent Sialo-Glycocluster Geetanjali Negi, Vinay Kumar Pandey, Poojitha Sai Potharaju, Manoj K. Jaiswal, Krishnan Harinivas Harshan, Vinod Kumar Tiwari, Nagma Parveen
8 [GO] 2025―Jun―05 Gut Microbiota and COVID-19: Unraveling the Gut-Lung Axis and Immunomodulatory Therapies Maria Cidinaria Silva Alves, Mireli Santana Rego, Ruana Carolina Cabral da Silva, Rousilândia de Araújo Silva, Igor Eduardo Silva Arruda, Sérgio de Sá Leitão Paiva-Júnior, Valdir de Queiroz Balbino
9 [GO] 2025―Jun―04 Single-Molecule Assay Reveals Binding Dynamics of SARS-CoV-2 Polymerase Components and Provides a New Tool to Distinguish Polymerase Inhibitors Terri C. Lovell, Heidi A. F. Dewling, Cynthia Li, Hery W. Lee, Calvin J. Gordon, Dana Kocincova, et al. (+4)
10 [GO] 2025―Mai―29 Influence of Steric and Electronic Properties of P2 Groups on Covalent Inhibitor Binding to SARS-CoV-2 Main Protease Dipendra Bhandari, Leighton Coates, Annie Aniana, John M. Louis, Peter V. Bonnesen, Andrey Kovalevsky
11 [GO] 2025―Apr―10 Mutagenesis-Guided Target Identification Reveals the Protein-Binding Domain of Nsp14 in Coronaviruses as the Target of a Labdane-Oxindole Compound Wei Shen Ho, Thinesshwary Yogarajah, Jasmaadiyah Binte Habib Mohameed, Deborah Yuhui Fong, Dorothy Hui Juan Cheong, Yi Hao Wong, et al. (+2)
12 [GO] 2025―Feb―28 Targeting Two-Tetrad RNA G-Quadruplex in the SARS-CoV-2 RNA Genome Using Tetraphenylethene Derivatives for Antiviral Therapy Payal Gupta, Rushikesh M. Khadake, Oinam Ningthemmani Singh, Harshad A. Mirgane, Dharmender Gupta, Sheshanath V. Bhosale, et al. (+3)
13 [GO] 2024―Nov―03 Global Health Priority Box─Proactive Pandemic Preparedness Anna Adam, Dominique Besson, Rob Bryant, Sarah Rees, Paul A. Willis, Jeremy N. Burrows, et al. (+8)
14 [GO] 2024―Sep―20 Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets Virginia K. James, Rianna N. Godula, Jessica M. Perez, Josh T. Beckham, Jamie P. Butalewicz, Sarah N. Sipe, et al. (+2)
15 [GO] 2024―Aug―28 Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2 Joshua W. C. Maxwell, Skye Stockdale, Erica L. Stewart, Caroline L. Ashley, Lachlan J. Smith, Megan Steain, et al. (+5)
16 [GO] 2024―Aug―03 4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses Michela Puxeddu, Manuela Donalisio, Joachim Jakob Bugert, Angela Corona, Paolo Cocomazzi, Mario Milani, et al. (+19)
17 [GO] 2024―Jun―24 P-selectin Facilitates SARS-CoV-2 Spike 1 Subunit Attachment to Vesicular Endothelium and Platelets Cheng Wang, Shaobo Wang, Xiangyu Ma, Xiaohong Yao, Kegang Zhan, Zai Wang, et al. (+8)
18 [GO] 2024―Mai―10 Enhanced Surface Accessibility of SARS-CoV-2 Omicron Spike Protein Due to an Altered Glycosylation Profile Dongxia Wang, Zijian Zhang, Jakub Baudys, Christopher Haynes, Sarah H. Osman, Bin Zhou, et al. (+2)
19 [GO] 2024―Apr―23 Discovery of C-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2 Eugen F. Mesaros, Benjamin J. Dugan, Min Gao, Muhammad Sheraz, Kayleigh McGovern-Gooch, Fran Xu, et al. (+17)
20 [GO] 2024―Mrz―13 Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance Julia M. Flynn, Sarah N. Zvornicanin, Tenzin Tsepal, Ala M. Shaqra, Nese Kurt Yilmaz, Weiping Jia, et al. (+4)
21 [GO] 2024―Feb―27 Synergistic Binding of SARS-CoV-2 to ACE2 and Gangliosides in Native Lipid Membranes Manorama Dey, Anurag Sharma, Garvita Dhanawat, Divya Gupta, Krishnan H. Harshan, Nagma Parveen
22 [GO] 2024―Feb―22 Ubiquitin Ligase Parkin Regulates the Stability of SARS-CoV-2 Main Protease and Suppresses Viral Replication Li Zhou, Ruochuan Liu, Heather Pathak, Xiaoyu Wang, Geon H. Jeong, Pratima Kumari, et al. (+2)
23 [GO] 2024―Jan―28 Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation Blake M. Hauser, Maya Sangesland, Evan C. Lam, Kerri J. St Denis, Maegan L. Sheehan, Mya L. Vu, et al. (+7)
24 [GO] 2024―Jan―25 A Mechanistic Understanding of the Modes of Ca2+ Ion Binding to the SARS-CoV-1 Fusion Peptide and Their Role in the Dynamics of Host Membrane Penetration Juliana Debrito Carten, George Khelashvili, Miya K. Bidon, Marco R. Straus, Tiffany Tang, Javier A. Jaimes, et al. (+3)
25 [GO] 2024―Jan―09 Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease Md Ashraf-Uz-Zaman, Teck Khiang Chua, Xin Li, Yuan Yao, Bala Krishna Moku, Chandra Bhushan Mishra, et al. (+3)
26 [GO] 2023―Okt―18 Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, Hayata Imamura, Francesco Pappone, Alfio Grillo, et al. (+14)
27 [GO] 2023―Okt―03 Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes Leah Mellett, Gaya Amarasinghe, Christopher W. Farnsworth, Shabaana A. Khader
28 [GO] 2023―Sep―20 Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors Nicole L. Inniss, Ján Kozic, Fengling Li, Monica Rosas-Lemus, George Minasov, Jiří Rybáček, et al. (+18)
29 [GO] 2023―Jun―30 Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease Julia M. Flynn, Qiu Yu J. Huang, Sarah N. Zvornicanin, Gila Schneider-Nachum, Ala M. Shaqra, Nese Kurt Yilmaz, et al. (+4)
30 [GO] 2023―Mai―11 hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics Chengbo Chen, Richard Zhu, Edgar A. Hodge, Marco A. Díaz-Salinas, Adam Nguyen, James B. Munro, Kelly K. Lee
31 [GO] 2023―Mai―05 SARS-CoV-2 Binding to Terminal Sialic Acid of Gangliosides Embedded in Lipid Membranes Geetanjali Negi, Anurag Sharma, Monika Chaudhary, Divya Gupta, Krishnan H. Harshan, Nagma Parveen
32 [GO] 2023―Apr―13 Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells Corina M. Stewart, Yuxia Bo, Kathy Fu, Mable Chan, Robert Kozak, Kim Yang-Ping Apperley, et al. (+6)
33 [GO] 2023―Apr―03 Identification of Human Host Substrates of the SARS-CoV-2 Mpro and PLpro Using Subtiligase N-Terminomics Shu Y. Luo, Eman W. Moussa, Joaquin Lopez-Orozco, Alberto Felix-Lopez, Ray Ishida, Nawell Fayad, et al. (+6)
34 [GO] 2023―Mrz―13 Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Hyeon-Min Cha, Uk-Il Kim, Soo Bin Ahn, Myoung Kyu Lee, Haemi Lee, Hyungtae Bang, et al. (+5)
35 [GO] 2023―Feb―03 Hybridization Chain Reaction Lateral Flow Assays for Amplified Instrument-Free At-Home SARS-CoV-2 Testing Samuel J. Schulte, Jining Huang, Niles A. Pierce
36 [GO] 2022―Okt―31 High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2 Rachel M. Sammons, Amanda L. Bohanon, Anvith Kowtha, Audrey Dejong, Eun Jeong Cho, Tamer S. Kaoud, Kevin N. Dalby
37 [GO] 2022―Okt―11 α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade Rui Qin, Emma Kurz, Shuhui Chen, Briana Zeck, Luis Chiribogas, Dana Jackson, et al. (+8)
38 [GO] 2022―Sep―26 Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry Sneha Ratnapriya, Anthony R. Braun, Héctor Cervera Benet, Danielle Carlson, Shilei Ding, Carolyn N. Paulson, et al. (+5)
39 [GO] 2022―Sep―21 Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, et al. (+4)
40 [GO] 2022―Sep―12 Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions Yongheng Rong, Xingyun Wang, Weian Mao, Fang Yuan, Min Chen, Shengjun Wang, et al. (+4)
41 [GO] 2022―Aug―31 A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses Ya-Qian Li, Cheng Yan, Xi-Feng Wang, Mao-Ying Xian, Guo-Qing Zou, Xiao-Fei Gao, et al. (+2)
42 [GO] 2022―Aug―18 Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity Ebba Samuelsson, Ekaterina Mirgorodskaya, Kristina Nyström, Malin Bäckström, Jan-Åke Liljeqvist, Rickard Nordén
43 [GO] 2022―Aug―08 Two Years into the COVID-19 Pandemic: Lessons Learned Severino Jefferson Ribeiro da Silva, Jessica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, et al. (+6)
44 [GO] 2022―Jul―22 Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2 Abraham J. Qavi, Chao Wu, Matthew Lloyd, Mohammad Mahabub-Uz Zaman, Jingyi Luan, Claire Ballman, et al. (+4)
45 [GO] 2022―Jul―13 Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors Aliakbar Khalili Yazdi, Paknoosh Pakarian, Sumera Perveen, Taraneh Hajian, Vijayaratnam Santhakumar, Albina Bolotokova, et al. (+2)
46 [GO] 2022―Jul―12 Raman Fingerprints of the SARS-CoV-2 Delta Variant and Mechanisms of Its Instantaneous Inactivation by Silicon Nitride Bioceramics Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, Hayata Imamura, Masaharu Shin-Ya, Tetsuya Adachi, et al. (+6)
47 [GO] 2022―Jun―29 Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity Marie O. Pohl, Laura Martin-Sancho, Ranjala Ratnayake, Kris M. White, Laura Riva, Qi-Yin Chen, et al. (+19)
48 [GO] 2022―Jun―24 Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern Ru-Yan Zhang, Shi-Hao Zhou, Chen-Bin He, Jian Wang, Yu Wen, Ran-Ran Feng, et al. (+3)
49 [GO] 2022―Jun―01 Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19 Jonathan H. Shrimp, John Janiszewski, Catherine Z. Chen, Miao Xu, Kelli M. Wilson, Stephen C. Kales, et al. (+11)
50 [GO] 2022―Mai―24 Pyronaridine Protects against SARS-CoV-2 Infection in Mouse Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Andre S. Godoy, Gabriela D. Noske, Aline M. Nakamura, et al. (+14)
51 [GO] 2022―Apr―15 A Highly Potent SARS-CoV-2 Blocking Lectin Protein Recep E. Ahan, Alireza Hanifehnezhad, Ebru Ş. Kehribar, Tuba C. Oguzoglu, Katalin Földes, Cemile E. Özçelik, et al. (+8)
52 [GO] 2022―Apr―11 Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang
53 [GO] 2022―Mrz―30 Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 Viola Denninger, Catherine K. Xu, Georg Meisl, Alexey S. Morgunov, Sebastian Fiedler, Alison Ilsley, et al. (+9)
54 [GO] 2022―Mrz―14 The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul Glossop, et al. (+10)
55 [GO] 2022―Mrz―09 A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant Albert To, Teri Ann S. Wong, Michael M. Lieberman, Karen Thompson, Aquena H. Ball, Laurent Pessaint, et al. (+11)
56 [GO] 2022―Feb―24 Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses Brendan T. Freitas, Daniil A. Ahiadorme, Rahul S. Bagul, Ian A. Durie, Samir Ghosh, Jarvis Hill, et al. (+13)
57 [GO] 2022―Feb―23 Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery Rumiana Tenchov, Qiongqiong Angela Zhou
58 [GO] 2022―Feb―08 Emerging Vaccine-Breakthrough SARS-CoV-2 Variants Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
59 [GO] 2021―Dez―03 Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview Rukmankesh Mehra, Kasper P. Kepp
60 [GO] 2021―Okt―21 Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus Oscar A. Ortega-Rivera, Sourabh Shukla, Matthew D. Shin, Angela Chen, Veronique Beiss, Miguel A. Moreno-Gonzalez, et al. (+5)
61 [GO] 2021―Okt―19 Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern Madalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, Kathy Fu, Geneviève Laroche, Zaid Taha, et al. (+24)
62 [GO] 2021―Okt―07 Reductionism Ad Absurdum: The Misadventures of Structural Biology in the Time of Coronavirus Dmitri Svetlov, Irina Artsimovitch
63 [GO] 2021―Sep―27 A Closer Look into FDA-EUA Approved Diagnostic Techniques of Covid-19 Hyunju Oh, Hyunjeong Ahn, Anubhav Tripathi
64 [GO] 2021―Sep―09 Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread Marco R. Straus, Miya K. Bidon, Tiffany Tang, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel
65 [GO] 2021―Aug―26 Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease Elizabeth A. MacDonald, Gary Frey, Mark N. Namchuk, Stephen C. Harrison, Stephen M. Hinshaw, Ian W. Windsor
66 [GO] 2021―Aug―02 Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model Steven Blake, Namir Shaabani, Lisa M. Eubanks, Junki Maruyama, John T. Manning, Nathan Beutler, et al. (+4)
67 [GO] 2021―Jul―30 Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis Rachna Singh, Anjna Kumari
68 [GO] 2021―Jul―28 Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection Amalia Z. Berna, Elikplim H. Akaho, Rebecca M. Harris, Morgan Congdon, Emilie Korn, Samuel Neher, et al. (+3)
69 [GO] 2021―Jul―14 Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S. Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, et al. (+28)
70 [GO] 2021―Jun―21 The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors Tomáš Otava, Michal Šála, Fengling Li, Jindřich Fanfrlík, Kanchan Devkota, Sumera Perveen, et al. (+6)
71 [GO] 2021―Jun―15 Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 Scott B. Biering, Erik Van Dis, Eddie Wehri, Livia H. Yamashiro, Xammy Nguyenla, Claire Dugast-Darzacq, et al. (+17)
72 [GO] 2021―Jun―03 Science at Its Best in the Time of the COVID-19 Pandemic Alon Herschhorn, Ashley T. Haase
73 [GO] 2021―Mai―26 Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp Jianyuan Zhao, Yongxin Zhang, Minghua Wang, Qian Liu, Xiaobo Lei, Meng Wu, et al. (+10)
74 [GO] 2021―Mai―21 The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease Nathanael D. Reynolds, Nathalie M. Aceves, Jinny L. Liu, Jaimee R. Compton, Dagmar H. Leary, Brendan T. Freitas, et al. (+5)
75 [GO] 2021―Mai―12 Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 Damir Bojadzic, Oscar Alcazar, Jinshui Chen, Sung-Ting Chuang, Jose M. Condor Capcha, Lina A. Shehadeh, Peter Buchwald
76 [GO] 2021―Apr―21 Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum Sebastian Fiedler, Monika A. Piziorska, Viola Denninger, Alexey S. Morgunov, Alison Ilsley, Anisa Y. Malik, et al. (+7)
77 [GO] 2021―Apr―16 Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone Cheng Wang, Shaobo Wang, Daixi Li, Peiqin Chen, Songling Han, Gaomei Zhao, et al. (+7)
78 [GO] 2021―Mrz―30 Inhibition of Human Coronaviruses by Antimalarial Peroxides Ayan Kumar Ghosh, Halli Miller, Konstance Knox, Madhuchhanda Kundu, Kelly J. Henrickson, Ravit Arav-Boger
79 [GO] 2021―Mrz―17 Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2 Simon Fink, Felix Ruoff, Aaron Stahl, Matthias Becker, Philipp Kaiser, Bjoern Traenkle, et al. (+15)
80 [GO] 2021―Mrz―08 Learning from COVID-19 to Tackle Antibiotic Resistance Manica Balasegaram
81 [GO] 2021―Mrz―01 Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang
82 [GO] 2021―Feb―13 Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, et al. (+10)
83 [GO] 2021―Jan―27 Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia Anggia Prasetyoputri
84 [GO] 2021―Jan―15 Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin Tiffany Tang, Javier A. Jaimes, Miya K. Bidon, Marco R. Straus, Susan Daniel, Gary R. Whittaker
85 [GO] 2021―Jan―13 Early Returns on Small Molecule Therapeutics for SARS-CoV-2 Mark N. Namchuk
86 [GO] 2020―Dez―22 Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? Andrew V. Stachulski, Joshua Taujanskas, Sophie L. Pate, Rajith K. R. Rajoli, Ghaith Aljayyoussi, Shaun H. Pennington, et al. (+7)
87 [GO] 2020―Dez―21 The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules Kirill Gorshkov, Catherine Z. Chen, Robert Bostwick, Lynn Rasmussen, Bruce Nguyen Tran, Yu-Shan Cheng, et al. (+20)
88 [GO] 2020―Dez―15 Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic Brayden G. Schindell, Meagan Allardice, Sandhini Lockman, Jason Kindrachuk
89 [GO] 2020―Dez―09 Recent Insights into Emerging Coronavirus: SARS-CoV-2 Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang
90 [GO] 2020―Dez―02 Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies Jonathan P. Davies, Katherine M. Almasy, Eli F. McDonald, Lars Plate
91 [GO] 2020―Nov―18 Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry Nicholas L. Dollman, Justin H. Griffin, Kevin M. Downard
92 [GO] 2020―Nov―13 High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2 Weiwei Wan, Shenglin Zhu, Shufen Li, Weijuan Shang, Ruxue Zhang, Hao Li, et al. (+4)
93 [GO] 2020―Nov―12 COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection? Adnan Hodžić, José de la Fuente, Alejandro Cabezas-Cruz
94 [GO] 2020―Okt―28 Targeting Crucial Host Factors of SARS-CoV-2 Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li
95 [GO] 2020―Sep―23 Targeting polyamines inhibits coronavirus infection by reducing cellular attachment Mason R Firpo, Vincent Mastrodomenico, Grant Hawkins, Matthieu Prot, Laura Levillayer, Thomas Gallagher, et al. (+2)
96 [GO] 2020―Sep―18 Structural, biophysical and biochemical elucidation of the SARS-CoV-2 nonstructural protein 3 macro domain Meng-Hsuan Lin, San-Chi Chang, Yi-Chih Chiu, Bo-Chen Jiang, Tsung-Han Wu, Chun-Hua Hsu
97 [GO] 2020―Aug―12 Comparative analysis of primer-probe sets for RT-qPCR of COVID-19 causative virus (SARS-CoV-2) Yujin Jung, Gun-Soo Park, Jun Hye Moon, Keun Bon Ku, Seung-Hwa Beak, Chang-Seop Lee, et al. (+12)
98 [GO] 2020―Aug―04 Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19 Severino Jefferson Ribeiro da Silva, Caroline silva, Klarissa Guarines, Renata Mendes, Keith M. Pardee, Alain Kohl, Lindomar Pena
99 [GO] 2020―Jul―20 Old drugs for a new virus: repurposed approaches for combating COVID-19 Sirle Saul, Shirit Einav
100 [GO] 2020―Jul―17 Current and Perspective Diagnostic Techniques for COVID-19 Xi Yuan, Chengming Yang, Qian He, Junhu Chen, Dongmei Yu, Jie Li, et al. (+5)
101 [GO] 2020―Jun―02 Current Perspective of Antiviral Strategies against COVID-19 Bintou Ahmadou Ahidjo, Marcus Loe, Yan Ling Ng, Chee Keng Mok, Justin Jang Hann Chu
102 [GO] 2020―Jun―01 COVID-19 and Other Pandemics: How Might They Be Prevented? Eric Oldfield, Satish R. Malwal
103 [GO] 2020―Mai―28 Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients Alexey Polonikov
104 [GO] 2020―Mai―19 Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease Brendan T Freitas, Ian A Durie, Jackelyn Murray, Jaron E Longo, Holden C Miller, David Crich, et al. (+3)
105 [GO] 2020―Mai―15 Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2? Cassandra L. Schrank, Kevin P. C. Minbiole, William M. Wuest
106 [GO] 2020―Mai―10 COVID-19: Living through Another Pandemic Essam Eldin A. Osman, Peter L. Toogood, Nouri Neamati
107 [GO] 2020―Apr―15 Correction: Immunodominant SARS Coronavirus Epitopes in Humans Elicited Both Enhancing and Neutralizing Effects on Infection in Non-human Primates Qidi Wang, Lianfeng Zhang, Kazuhiko Kuwahara, Li Li, Zijie Liu, Taisheng Li, et al. (+8)
 [1] 

107 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec